Exosomes derived from tumor adjacent fibroblasts efficiently target pancreatic tumors
Open Access
- 9 April 2024
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 14 (7) , 3009-3026
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancerBiomedicine & Pharmacotherapy, 2022
- Extracellular vesicles as an emerging drug delivery system for cancer treatment: Current strategies and recent advancesBiomedicine & Pharmacotherapy, 2022
- Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancerBiomaterials, 2019
- Extracellular vesicles for personalized medicine: The input of physically triggered production, loading and theranostic propertiesAdvanced Drug Delivery Reviews, 2019
- Tumor targeting via EPR: Strategies to enhance patient responsesAdvanced Drug Delivery Reviews, 2018
- Cancer Associated Fibroblasts: The Architects of Stroma RemodelingProteomics, 2018
- Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challengesActa Pharmaceutica Sinica B, 2016
- The Molecular Taxonomy of Primary Prostate CancerCell, 2015
- Ormeloxifene efficiently inhibits ovarian cancer growthCancer Letters, 2015
- A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapyBiomaterials, 2014